Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion‐positive prostate cancers
A Krohn, A Seidel, L Burkhardt… - The Journal of …, 2013 - Wiley Online Library
Deletion of 3p13 has been reported from about 20% of prostate cancers. The clinical
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion‐positive prostate cancers
A Krohn, A Seidel, L Burkhardt, F Bachmann… - The Journal of …, 2013 - infona.pl
Deletion of 3p13 has been reported from about 20% of prostate cancers. The clinical
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.
A Krohn, A Seidel, L Burkhardt… - Journal of …, 2013 - search.ebscohost.com
Deletion of 3p13 has been reported from about 20% of prostate cancers. The clinical
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.
A Krohn, A Seidel, L Burkhardt, F Bachmann… - The Journal of …, 2013 - europepmc.org
Deletion of 3p13 has been reported from about 20% of prostate cancers. The clinical
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
[引用][C] Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
A Krohn, A Seidel, L Burkhardt, F Bachmann… - The Journal of …, 2013 - cir.nii.ac.jp
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct
subgroup of aggressive <i>ERG</i> fusion-positive prostate cancers | CiNii Research CiNii …
subgroup of aggressive <i>ERG</i> fusion-positive prostate cancers | CiNii Research CiNii …
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
A Krohn, A Seidel, L Burkhardt… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Deletion of 3p13 has been reported from about 20% of prostate cancers. The clinical
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …
significance of this alteration and the tumour suppressor gene (s) driving the deletion remain …